camptothecin has been researched along with dimethyl sulfoxide in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (15.79) | 18.7374 |
| 1990's | 10 (52.63) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chiao, C; Li, H | 1 |
| Kondo, K; Kume, T; Oishi, M; Shiraishi, T; Tsuneizumi, K; Watanabe, T | 1 |
| D'Arpa, P; Liu, LF; Tsao, YP | 1 |
| Herrera, RE; Nordheim, A; Stewart, AF | 1 |
| Strauss, PR | 1 |
| Chiao, CY; Li, HS | 1 |
| Bhuyan, BK; Fraser, TJ | 1 |
| Darzynkiewicz, Z; Del Bino, G; Li, X; Traganos, F | 1 |
| Boothman, DA; Church, DR; Frydman, B; Hutson, P; Planchon, SM; Wilding, G; Witiak, DT; Wuerzberger, S | 1 |
| Agurell, E; Cederberg, H; Hedenskog, M; Rannug, U | 1 |
| Gorczyca, W; Melamed, MR; Pizzolo, JG; Qiao, L | 1 |
| Darzynkiewicz, Z; Degraef, C; Del Bino, G; Fokan, D; Galand, P; Mosselmans, R | 1 |
| Cruz, M; Eneroth, P; Sidén, A; Vargas, VI; Yakisich, JS | 1 |
| Pandolfi, PP; Rasheed, ZA; Ravee, Y; Rubin, EH; Saleem, A | 1 |
| Cai, H; Chen, S; Hotz, K; La Placa, DB; Nguyen, N; Peterkin, V; Stevens, JC; Tukey, RH; Yang, YS | 1 |
| Jiang, R; Li, Y; Sun, Z; Wang, D; Zhang, Q; Zhao, D; Zhao, X; Zu, B; Zu, Y | 1 |
| Du, J; Huang, C; Huang, S; Huang, W; Li, Y | 1 |
| Chu, X; Hao, A; Li, S; Liu, G; Ma, M; Shang, W; Xing, P; Zhang, Y | 1 |
19 other study(ies) available for camptothecin and dimethyl sulfoxide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of topical use of camptothecine-dimethyl sulfoxide solution in psoriasis.
Topics: Administration, Topical; Adult; Camptothecin; Dimethyl Sulfoxide; Female; Humans; Male; Middle Aged; Psoriasis | 1975 |
Synergistic induction of erythroid differentiation of mouse erythroleukemia (MEL) cells by inhibitors of topoisomerases and protein tyrosine kinases.
Topics: Acetamides; Amsacrine; Animals; Blotting, Western; Camptothecin; Cell Differentiation; Cinnamates; Dimethyl Sulfoxide; Hemoglobins; Leukemia, Erythroblastic, Acute; Mice; Mitomycin; Protein-Tyrosine Kinases; Sulfides; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vanadates | 1992 |
The involvement of active DNA synthesis in camptothecin-induced G2 arrest: altered regulation of p34cdc2/cyclin B.
Topics: Aphidicolin; Camptothecin; CDC2 Protein Kinase; Cyclins; Dimethyl Sulfoxide; DNA Damage; DNA Replication; DNA Topoisomerases, Type I; G2 Phase; HeLa Cells; Humans; Kinetics; Methionine; Models, Biological; Neoplasm Proteins; Protamine Kinase; S Phase | 1992 |
Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities.
Topics: Animals; Blotting, Northern; Calcimycin; Camptothecin; Cell Line; Dimethyl Sulfoxide; DNA Topoisomerases, Type I; Gene Expression Regulation; Humans; Kinetics; Plasmids; Protein-Tyrosine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogenes; Restriction Mapping; RNA Polymerase II; RNA, Messenger; Thymus Gland; Transcription, Genetic | 1990 |
Topoisomerase inhibitors suppress release of globin sequences into small soluble DNA in erythroblasts.
Topics: Anemia; Animals; Camptothecin; Chromatin; Dimethyl Sulfoxide; DNA; DNA Damage; Drug Synergism; Erythroblasts; Genes; Globins; Mice; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Transcription, Genetic | 1990 |
[Observation on the effect of camptothecin-dimethyl sulfoxide solution on psoriasis].
Topics: Administration, Topical; Adult; Camptothecin; Dimethyl Sulfoxide; Female; Humans; Male; Psoriasis | 1974 |
Frozen DON cells as a source for a cell cycle assay of antitumor agents.
Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Biological Assay; Camptothecin; Carbazoles; Cell Division; Cell Line; Cell Survival; Cricetinae; Cryoprotective Agents; Cytarabine; Cytological Techniques; Dactinomycin; Dimethyl Sulfoxide; Floxuridine; Formates; Freezing; Glycerol; Hydroxyurea; Lung; Mitosis; Proteins; Pyridines; Ribonucleosides; Thiosemicarbazones; Time Factors | 1974 |
Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs.
Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Camptothecin; Cell Cycle; Cell Differentiation; Dimethyl Sulfoxide; DNA, Neoplasm; Humans; Hyperthermia, Induced; Leukemia, Promyelocytic, Acute; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured | 1994 |
Beta-lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53-independent response.
Topics: Apoptosis; Breast Neoplasms; Camptothecin; Cell Division; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; G1 Phase; Humans; Leukemia, Promyelocytic, Acute; Male; Naphthoquinones; Prostatic Neoplasms; Resting Phase, Cell Cycle; Time Factors; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1995 |
Chemically induced changes in the spectrum of amplifications of the human minisatellite MS1 integrated in chromosome III of a haploid yeast strain.
Topics: Alleles; Camptothecin; Chromosomes, Fungal; Dimethyl Sulfoxide; DNA, Satellite; Epoxy Compounds; Ethylene Oxide; Gene Amplification; Haploidy; Humans; Methyl Methanesulfonate; Polychlorinated Dibenzodioxins; Repetitive Sequences, Nucleic Acid; Reserpine; Saccharomyces cerevisiae | 1994 |
p145 expression during the cell cycle in HL-60 cell line and normal human lymphocytes: effects of camptothecin, vinblastine, cycloheximide, actinomycin D, retinoic acid and DMSO.
Topics: Antigens, Nuclear; Antineoplastic Agents; Camptothecin; Cell Cycle; Cell Differentiation; Cycloheximide; Dactinomycin; Dimethyl Sulfoxide; Flow Cytometry; Humans; Lymphocyte Activation; Lymphocytes; Nuclear Proteins; Tretinoin; Tumor Cells, Cultured; Vinblastine | 1993 |
Comparison of methods based on annexin-V binding, DNA content or TUNEL for evaluating cell death in HL-60 and adherent MCF-7 cells.
Topics: Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Camptothecin; Cytological Techniques; Dimethyl Sulfoxide; DNA Fragmentation; DNA Nucleotidylexotransferase; DNA, Neoplasm; HL-60 Cells; Humans; In Situ Nick-End Labeling; Solvents | 1999 |
Early effects of protein kinase modulators on DNA synthesis in rat cerebral cortex.
Topics: Animals; Anti-Inflammatory Agents; Benzoquinones; Camptothecin; Cerebral Cortex; Dimethyl Sulfoxide; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Superhelical; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Genistein; Lactams, Macrocyclic; Naphthalenes; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Phosphotyrosine; Protein-Tyrosine Kinases; Quinones; Rats; Rats, Sprague-Dawley; Rifabutin; Staurosporine; Steroids; Vanadates | 1999 |
The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
Topics: Amino Acid Sequence; Animals; Binding Sites; Camptothecin; Carrier Proteins; Cell Nucleus; Chromosome Mapping; Dichlororibofuranosylbenzimidazole; Dimethyl Sulfoxide; DNA Topoisomerases, Type I; DNA-Binding Proteins; HeLa Cells; Humans; Leukemia, Promyelocytic, Acute; Mice; Molecular Sequence Data; Neoplasm Proteins; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Promyelocytic Leukemia Protein; Rabbits; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Topoisomerase I Inhibitors; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Zinc Fingers | 2002 |
A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation.
Topics: Alleles; Animals; Anticholesteremic Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Azetidines; Biocatalysis; Camptothecin; Dimethyl Sulfoxide; Enzyme Induction; Ezetimibe; Gene Expression; Glucuronic Acid; Glucuronosyltransferase; Humans; Irinotecan; Kinetics; Liver; Male; Metabolic Clearance Rate; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microsomes, Liver; Models, Animal; Naloxone; Pharmaceutical Preparations; Phenobarbital; UDP-Glucuronosyltransferase 1A9 | 2010 |
A novel preparation method for camptothecin (CPT) loaded folic acid conjugated dextran tumor-targeted nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Camptothecin; Carbon Dioxide; Chemistry, Pharmaceutical; Dextrans; Dimethyl Sulfoxide; Drug Carriers; Folic Acid; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Spectroscopy, Fourier Transform Infrared; Surface Properties; X-Ray Diffraction | 2011 |
Screening of anti-cancer agent using zebrafish: comparison with the MTT assay.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Camptothecin; Cell Line, Tumor; Coloring Agents; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; Emodin; Gene Expression; Humans; Lignans; Naphthoquinones; Rotenone; Tetrazolium Salts; Thiazoles; Transcriptional Activation; Tumor Suppressor Protein p53; Zebrafish | 2012 |
A supramolecular vesicle of camptothecin for its water dispersion and controllable releasing.
Topics: Antineoplastic Agents; beta-Cyclodextrins; Camptothecin; Dimethyl Sulfoxide; Drug Liberation; HeLa Cells; Humans; Membranes, Artificial; Water | 2015 |